Daiichi Sankyo Co Ltd

About

Daiichi Sankyo Co., Ltd. is a Tokyo-based global pharmaceutical company that discovers, develops, manufactures and markets prescription medicines, with a focus on oncology, cardiovascular and other therapeutic areas. The company has a strong research emphasis on antibody–drug conjugates and targeted therapies and co-developed the breast cancer drug trastuzumab deruxtecan (Enhertu) with AstraZeneca, while also marketing anticoagulant therapies in multiple markets. As one of Japan’s largest drugmakers, Daiichi Sankyo combines a robust domestic presence with ongoing efforts to expand its international footprint through partnerships and pipeline commercialization.